Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer

Trial Profile

Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Oct 2017

At a glance

  • Drugs Fluvastatin (Primary) ; Pimonidazole
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Oct 2017 Status changed from recruiting to completed.
    • 10 Jun 2017 Biomarkers information updated
    • 20 Jun 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Sep 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top